Posted inNews and Updates
Can Medical Cannabis Reduce Agitation in Dementia Patients?
New research indicates medical cannabis may safely reduce agitation in dementia patients, offering a potential alternative to traditional antipsychotics.
Posted inNews and Updates
FDA Clears Subcutaneous Leqembi for Early Alzheimer’s
The FDA has approved the subcutaneous injection of Leqembi for early Alzheimer’s. Learn how this new delivery method impacts patient care and treatment.
Posted inNews and Updates
FDA Releases Final Guidance on Psychedelic Drug Trials
The FDA has issued final guidance for psychedelic drug clinical trials, offering new clarity on safety, study design, and patient monitoring protocols.
Posted inNews and Updates
Bariatric Surgery Proven Safe for Obese Youth
New research confirms bariatric surgery is a safe, effective option for treating severe obesity in adolescents, improving long-term metabolic health outcomes.
Posted inNews and Updates
FDA Rejects Hengrui-Elevar Liver Cancer Drug Again
The FDA rejects Hengrui-Elevar's liver cancer drug for the third time, while GSK prepares for an FDA filing to expand Jemperli for rectal cancer treatment.
Posted inNews and Updates
Stem Cell Therapy Shows Promise for Spinal Cord Injuries
New stem cell therapy advances to clinical trials, offering hope for spinal cord injury recovery through regenerative nerve cell transplantation.
Posted inNews and Updates
New Weight Management Drug Trial: What Patients Should Know
A new clinical trial is testing a breakthrough drug for weight management. Discover how this potential treatment could impact metabolic health and diabetes.
Posted inNews and Updates
US FDA Issues Warning to Alembic Bioequivalence Investigator
The US FDA issued a warning letter to a clinical investigator at an Alembic bioequivalence site over concerns regarding data integrity and study oversight.
Posted inNews and Updates
Can Ibuprofen Help Treat Drug-Resistant Tuberculosis?
New research suggests ibuprofen may safely reduce inflammation in drug-resistant tuberculosis patients, potentially improving outcomes for MDR-TB recovery.
Posted inNews and Updates
Massive Bio and Sequence Me Now Partner to Boost Cancer Trials
Massive Bio and Sequence Me Now partner to revolutionize cancer clinical trial recruitment using AI to connect patients with precision medicine research.